Cannabis-based cannabinoids and sleep-restricted stress study in healthy adults
Official title: Challenging the Endocannabinoid System in Sleep Restricted Healthy Volunteers to Modulate Physiological Arousal (CANISLEEP) Study
Run by King's College London · NCT07656350 · Data updated 2026-11-12
This study tests whether THC, CBD, or a combination can influence stress and arousal in sleep-deprived healthy adults who report higher anxiety.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | King's College London Academic / other |
| Locations | 1 site (London, London) |
| Status | Recruiting |
| Started | June 2, 2026 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | June 18, 2026 |
| Trial ID | NCT07656350 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18-60 with higher-than-average anxiety (GAD-7 ≥ 10) willing to undergo short-term sleep restriction and adhere to study requirements.
✕Probably not a fit
Individuals with current psychiatric treatment, recent cannabinoid use, or certain cannabinoid contraindications may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Healthy adults aged 18-60 who report above-average stress and anxiety will undergo a brief sleep restriction to 4 hours, then receive one of four treatments: THC, CBD, THC + CBD, or placebo. The study uses physiological and psychological measures to see how these cannabinoid oils affect stress responses after sleep loss. It is designed to be a short-duration, multiple-arm trial with careful screening to exclude recent cannabinoid use and psychiatric treatment. The objective is to understand how endocannabinoid-system–targeting cannabinoids interact with sleep-restricted stress in otherwise healthy individuals.
Why it matters
Potential benefit: If successful, results could inform how cannabinoid-based products modulate stress and arousal in sleep-deprived individuals.
How similar studies have gone: Prior research suggests cannabinoids can influence stress and sleep processes, but this specific sleep-restriction, anxiety-focused, healthy-volunteer design is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Aged 18-60 2. Currently experiencing higher than average anxiety (measured by a score of ≥10 on the GAD-7) 3. Able and willing to restrict their sleep to 4 hours on one occasion 4. Willing to restrict alcohol and recreational drug intake during time on the study, confirmed by negative urine drug screen on the day of the experimental session 5. Own a functioning phone and be able to respond to text messages 6. Willing to provide GP details 7. Willing to provide an emergency contact 8. Able to provide written informed consent 9. Willing to use a highly effective contraceptive method (see Section 5.2.2) for the duration of the study. Exclusion Criteria: 1. Currently receiving any treatment for any psychiatric disorder (medication and/or professional psychotherapy for a mental disorder) 2. Any cannabinoid use in the past 3 months, including CBD oil, medical cannabinoids or recreational cannabis/THC use 3. Cannabinoid contraindications: lifetime history of psychosis, 1st degree relative with psychosis, lifetime substance use disorder (that was professionally treated) 4. History of consistent (\>12 months) monthly cannabis use 5. Currently experiencing insomnia or irregular sleep pattern (e.g. night shift work) 6. Sleep restriction contraindications (sleep apnoea, sleep movement disorder, night shift work, insomnia) 7. Have excessive daily caffeine intake (\>4 cups of coffee per day or equivalent) 8. Unlikely to be able to complete the study procedures for any reason, as judged by the study team 9. Currently pregnant or lactating 10. Currently trying to conceive a child Additional criteria which must be met on experimental visits: 1. Negative urine drug screen 2. Negative urine pregnancy test 3. Negative alcohol breath test
Where it's running
-
The Centre for Mental Health Research and Innovation
London, London, United Kingdom Recruiting
Study contacts
- Principal investigator: Will Lawn, PhD — King's College London
- Study coordinator: Catherine I V Bird, MSc
- Email: catherine.bird@kcl.ac.uk
- Phone: +44(0)2032281590
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Improved method to measure bone blood flow with total-body PET/CT in healthy adults
This study tests whether a whole-body PET/CT scan using a safe radioactive tracer can measure bone blood flow in healthy volunteers aged over 50.
-
Arterial stiffness in children and young people with CKD and hypertension
This study will test whether arterial stiffness is higher in children and young people with chronic kidney disease and high blood pressure compared with their peers, using a one-time assessment and follow-up for those with high BP.
-
Colchicine in dialysis patients: a feasibility test
This study tests whether a low daily dose of colchicine is tolerable for adults on haemodialysis over 3 months.
-
Novel functional snack and perimenopause: does a fibre- and phytochemical-rich bite help symptoms?
A daily snack enriched with phytochemicals and fiber is being tested to see if it can reduce perimenopausal symptoms and improve well-being in women aged 40–55 who are not using hormone therapy.
-
Effects of plant foods on gut health and heart health in healthy adults
This study tests whether two plant-based diets have different effects on gut microbiota diversity and metabolic health in healthy adults aged 30–70.
-
Coronary stents for people with HFpEF and blocked heart arteries
This trial will see if placing coronary artery stents (versus a placebo procedure) helps people with HFpEF and coronary artery disease feel better over six months.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.